Schizophrenia Screening, Prevention and Management

Schizophrenia is a rare mental health condition and the factors involved in its progression are unclear, making it difficult to screen for and prevent. There appears to be a genetic link, as the condition often tends to run in families, but it also depends on certain features of the brain and environmental circumstances.

Image Credit: Lightspring /


Screening for schizophrenia is difficult because there are no reliable markers to indicate the subsequent development of the condition. Additionally, it is a relatively rare condition, making it difficult for screening initiatives to offer cost-effective benefits to the general population that justify the means used to run the program.

There have been some public health campaigns aimed to educate the general public about schizophrenia, specific risk factors and early symptoms of the disease. These initiatives were intended to help detect individuals with the condition earlier and intervene with treatment as soon as possible. However, the relative efficacy and effect of these campaigns, when considering their costs, has not been clearly established.


Similarly to the screening for schizophrenia, prevention of the disease poses a challenge because we are not able to accurately determine which individuals are most likely to be affected.

Substance abuse is strongly linked to schizophrenia, with regular drug users more likely to suffer from the condition and a high percentage of schizophrenic patients who have a history of drug abuse. For this reason, the avoidance of drugs such as cannabis, cocaine and amphetamines is recommended in the prevention of schizophrenia.

Social support is also very important for individuals to manage stressful life events and prevent triggers for the initiation of schizophrenia from occurring. Where possible, people at risk should have a network they can trust to talk through any issues with and avoid isolation.

Schizophrenia: Assessment – Psychiatry | Lecturio

Early intervention

There is some scientific evidence to support the use of early interventions to prevent the progression of an at-risk individual into suffering from schizophrenia. It is proposed that these interventions help to improve short-term outcomes, although the overall benefit over time is not clear.

Individuals who are most likely to benefit include those who have experienced a single psychotic episode. Cognitive behavior therapy (CBT) may help to reduce the risk of a subsequent episode and help patients prevent progression to schizophrenia.


There are a number of management techniques that may be recommended for patients with schizophrenia.

Pharmacotherapy with antipsychotic drugs is almost always suggested to help patients manage thier symptoms. These types of drugs often offer an effective solution to reduce symptoms, particularly the positive symptoms such as hallucinations and delusions. Despite their utility, these drugs are typically less effective in the treatment of negative symptoms, such as disorganized thinking and behaviour.

In addition, psychotherapy is a very helpful tool in the management of schizophrenia. There are various different types of therapy, which may be delivered on an individual basis with the therapist, in a group situation or inclusive of family members and people who care for the patient with schizophrenia.

Psychotherapy is important, as it enables patients to work through any issues or concerns they may have and address stressful situations before they develop into a psychotic episode.


Further Reading

Last Updated: Sep 25, 2022

Susan Chow

Written by

Susan Chow

Susan holds a Ph.D in cell and molecular biology from Dartmouth College in the United States and is also a certified editor in the life sciences (ELS). She worked in a diabetes research lab for many years before becoming a medical and scientific writer. Susan loves to write about all aspects of science and medicine but is particularly passionate about sharing advances in cancer therapies. Outside of work, Susan enjoys reading, spending time at the lake, and watching her sons play sports.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chow, Susan. (2022, September 25). Schizophrenia Screening, Prevention and Management. News-Medical. Retrieved on September 26, 2022 from

  • MLA

    Chow, Susan. "Schizophrenia Screening, Prevention and Management". News-Medical. 26 September 2022. <>.

  • Chicago

    Chow, Susan. "Schizophrenia Screening, Prevention and Management". News-Medical. (accessed September 26, 2022).

  • Harvard

    Chow, Susan. 2022. Schizophrenia Screening, Prevention and Management. News-Medical, viewed 26 September 2022,


  1. meriem mimi meriem mimi Algeria says:

    thank you so mush susan you are helping me to understand what is happening to me.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
New study advances the understanding of genetic basis of autism